Transplant Psychiatry Transplant Psychiatry Curley L. Bonds, MD Curley L. Bonds, MD Associate Professor & Chair Associate Professor & Chair Department of Psychiatry & Human Department of Psychiatry & Human Behavior Behavior Charles Drew University School of Charles Drew University School of Medicine Medicine Associate Clinical Professor & Vice- Associate Clinical Professor & Vice- Chair Chair Department of Psychiatry Department of Psychiatry David Geffen School of Medicine at UCLA David Geffen School of Medicine at UCLA
67
Embed
Transplant Psychiatry Curley L. Bonds, MD Associate Professor & Chair Department of Psychiatry & Human Behavior Charles Drew University School of Medicine.
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Transplant PsychiatryTransplant Psychiatry
Curley L. Bonds, MDCurley L. Bonds, MDAssociate Professor & ChairAssociate Professor & Chair
Department of Psychiatry & Human Department of Psychiatry & Human BehaviorBehavior
Charles Drew University School of Charles Drew University School of MedicineMedicine
Associate Clinical Professor & Vice-ChairAssociate Clinical Professor & Vice-ChairDepartment of PsychiatryDepartment of Psychiatry
David Geffen School of Medicine at UCLADavid Geffen School of Medicine at UCLA
Overview
• Brief overview of solid organ transplantation• Rationale for psychosocial screening• Role of psychosocial screening• Predictive value of psychosocial assessment • Pre-operative and post-operative issues• Pharmacological aspects of cardiac
transplantation• Challenges for the Organ Transplant
Psychiatrist
Scope of Solid Organ Transplantation
• Kidney• Kidney/Pancreas• Liver• Heart • Lung• Small Bowel• Special Senses (Cornea, Cochlea,
etc.)• Limbs (Face, Hand)
History of Organ Transplantation
• First successful transplant: 1951 (kidney)
• First partial success: 1953 (kidney, patient survived 175 days)
• First twin-to-twin transplant: 1954 (patient survived until 1962)
Waiting List as of 1/21/07
94,759 Waiting list candidates
24,438 Transplants (January - October 2006)
12,395 Donors(January - October 2006)
UNOS website data
The Transplant Team
• Transplant Surgeon• Internists & Sub-specialists• Psychiatrist/Psychologist• Transplant Coordinators/Nurses• Social Worker• Ethicists/Pastoral Services• Community Members
Pre-Transplant Evaluation
• Psychosocial Assessment– Past Psychiatric History– Current psychiatric symptoms/illness– Psychotropic use– Substance use history– Social support– Cognitive evaluation– Understanding & Knowledge
Determining Transplant Candidacy
PsychPsych
So
cial
So
cial
BioBio
AssessmentAssessment
Biopsychosocial Screening
Suitability for Transplant
ComplianceSocial Supports
Understanding &Knowledge
Recipient’s History and Habits
The Transplant Patient
Biological, psychiatric and ethical issues in organ transplantation
• Learn whether the patient will be able to form collaborative relationships with team and comply with medical regimen
• Assess substance abuse history and recovery, and predict patient’s ability to maintain abstinence
• Help the team get to know the patient as a person to provide better care
Rationale for Psychosocial Screening
• To learn about the psychosocial needs of the patient and family, and plan for services during the waiting, recovery, and rehab phases of the transplant process
• To establish baseline measures of mental functioning to monitor post-op changes
Rationale for Psychosocial Screening
• Predict the recipient's ability to cope with the stresses of surgery
• Identify co-morbid mental illnesses and plan interventions for them
• Ensure adequate education and understanding/informed consent
Psychological evolution and assessment in patients
undergoing OHT
Triffaux, Wauthy, Bertrand et al.European Psychiatry 2001: 16: 180-5
1 year survivalrehospitalizationsinfectionsrejections
Predictive Value of Pre-Op Assessment
• Group I (n=25) Any Axis I Dx• Group II (n=82) No Axis I Dx
• Findings: No significant difference between Groups I and II at 1 year
• Implications
GuiltGuilt
Anx
iety
Anx
iety
Depression
Depression
Dis
abili
ty
Dis
abili
ty
WaitingWaiting
Pre-Operative Issues
UNOS Heart Allocation Policy
• Status 1A Pt requires: Continuous hemodynamic monitoring and cardiac or pulmonary assistance with one or more of the following:
- cont. IV or inotropes- left and/or right ventricular assist system- intraaortic balloon pump or ventilator for
pts<45- all pts < 6 months old
• Status 1BPt requires: a circulatory assist device or admission to an acute care hospital and continuous infusion of IV inotropes
UNOS Heart Allocation Policy
• Status 2APatient requires continuous infusion of IV inotropes
• Status 2BPatients needing a heart transplant but not meeting criteria for 1A, 1B or 2A
Pre-Operative Interventions
• Transplant Support Group• Internet/Online Support Groups• National Heart Association• Transplant Olympics• Individual Psychotherapy• Antidepressants/Anxiolytics
Body Image
Body Image
New
Med
s
New
Med
s
Role Strain
Role Strain
Fina
ncia
l
Fina
ncia
l
RehabilitationRehabilitation
Post-Operative Issues
1st Three Years after OHT
• 191 OHT recipients were followed for 3 years:– Major Depressive Disorder
25.5%– Adjustment Disorders
20.8%– PTSD-T 17%– Any Disorder 38%
Dew, Kormos, et al Psychosomatics2000
Psychological Changes in the Recipient
• Castelnuovo-Tedesco– Expansion of body image– Incorporation of a non-ego ‘part object’ – Ambivalence towards a live-giving
object that can also be lethal
“This is the matrix in which one finds besides depression, blissful euphoria or paranoid dread.”
Ageism and Transplantation
• Most US Transplant Programs use age 65 as an automatic cut off for transplantation
• Medical data now shows that transcipients over 65 can do as well as younger patients
• Led to the Alternate Transplant List at UCLA
UCLA Experience
Subjects with Axis I Disorders vs Subjects with No Psychiatric Disorders*
3
24
19 19 19
2
24
29
44
20
0
5
10
15
20
25
30
35
40
45
50
Mortality 1 Year Rejection 1 Year Infection 2 Year Infection Readmissions
Pe
rce
nta
ge
Subjects with Axis I Disorders(N=21)
Subjects with No PsychiatricDisorders (N=31)
*p values insignificant
UCLA Alternate Transplant List
Subjects >65, Axis I Disorders vs No Psychiatric Disorders*
0
33
67 67
33
0
67
83 83
50
0
10
20
30
40
50
60
70
80
90
Mortality 1 Year Rejection 1 Year Infection 2 Year Infection Readmissions
Pe
rce
nta
ge
Subjects >65 with Axis I Disorders(N=3)Subjects >65 with No PsychiatricDisorders (N=6)
*p values insignificant
UCLA Experience: Axis II Pathology
Subjects with Axis II Disorders vs Subjects with No Psychiatric Disorders*
0
67
33
67
0
3
24
29
44
20
0
10
20
30
40
50
60
70
80
Mortality 1 Year Rejection 1 Year Infection 2 Year Infection Readmissions
Pe
rce
nta
ge
Subjects with Axis II Disorders(N=3)
Subjects with No PsychiatricDisorders (N=24)
*p values insignificant
Psychiatric Evaluations of Heart Transplant Candidates: Predicting Post-Transplant Hospitalizations, Rejection Episodes, and Survival
• There is no consensus among clinicians about which candidates are acceptable or unacceptable
• While psychosocial risk factors are routinely used to determine candidacy, there is limited predictive validity of the methods used
Hypothesis
• Previously identified psychiatric risk factors (eg. Recent substance abuse, history of suicide attempt, having a personality disorder, low levels of social support, and poor past adherence to medical regimens) would be associated with a greater likelihood of post-transplant complications
Outcome Measures
• Re-hospitalization/Rejection• Infection• Death
Methods
• 108 OHT recipients followed for average of 970 days
• Transplanted between 1997 and 2000
• >18 years old• Followed by UCLA Heart Transplant
Team
Findings –Psychiatric Risk Factors
• 77.8 had evidence of current Axis I disorder at time of evaluation– 40.4% mood disorder– 30.8% depression-related dx– 14.4% anxiety-related dx– 6.7% sleep disorder– 27.8% ETOH dependence or abuse
• 5.6% actively dependent on ETOH
• 41.7% using psychotropic meds
Risk Assessment
• Good Candidates – 50%• High Risk- 11.1%
Predictors of Transplant Outcomes
• Increasing psychiatric risk classification was associated with a greater hazard of post-transplant mortality, but was not predictive of either post-transplant infection (p=0.10) or hospitalization (p=0.62)
• Past history of suicide attempt strongly associated with time to infection/rejection
Predictors of Death
• 5 variables were associated with survival– Current employment (increases)– Hx of drug or ETOH detox– Current depressive disorder– Hx of past suicide attempt– Hx of poor medical adherence
Predictors of High Risk Classification
• Poor adherence• Past psychiatric hospitalization• Mood disorder• Axis II disorder• Use of psychiatric medications• Hx of ETOH or drug detox• Hx of substance abuse• Lack of social support
Demographic Predictors of Risk
• Age (younger)• Marital status (single)• Gender (female)
Survival as a Function of Psych Risk
Neuropsychiatric Aspects of Immunosuppressive Agents